EconPapers    
Economics at your fingertips  
 

Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function

Liad Hinden, Majdoleen Ahmad, Sharleen Hamad, Alina Nemirovski, Gergő Szanda, Sandra Glasmacher, Aviram Kogot-Levin, Rinat Abramovitch, Bernard Thorens, Jürg Gertsch, Gil Leibowitz and Joseph Tam ()
Additional contact information
Liad Hinden: The Hebrew University of Jerusalem
Majdoleen Ahmad: The Hebrew University of Jerusalem
Sharleen Hamad: The Hebrew University of Jerusalem
Alina Nemirovski: The Hebrew University of Jerusalem
Gergő Szanda: Department of Physiology, Semmelweis University
Sandra Glasmacher: University of Bern
Aviram Kogot-Levin: Hadassah-Hebrew University Medical Center
Rinat Abramovitch: Hadassah-Hebrew University Medical Center
Bernard Thorens: University of Lausanne
Jürg Gertsch: University of Bern
Gil Leibowitz: Hadassah-Hebrew University Medical Center
Joseph Tam: The Hebrew University of Jerusalem

Nature Communications, 2022, vol. 13, issue 1, 1-18

Abstract: Abstract Activation of the cannabinoid-1 receptor (CB1R) and the mammalian target of rapamycin complex 1 (mTORC1) in the renal proximal tubular cells (RPTCs) contributes to the development of diabetic kidney disease (DKD). However, the CB1R/mTORC1 signaling axis in the kidney has not been described yet. We show here that hyperglycemia-induced endocannabinoid/CB1R stimulation increased mTORC1 activity, enhancing the transcription of the facilitative glucose transporter 2 (GLUT2) and leading to the development of DKD in mice; this effect was ameliorated by specific RPTCs ablation of GLUT2. Conversely, CB1R maintained the normal activity of mTORC1 by preventing the cellular excess of amino acids during normoglycemia. Our findings highlight a novel molecular mechanism by which the activation of mTORC1 in RPTCs is tightly controlled by CB1R, either by enhancing the reabsorption of glucose and inducing kidney dysfunction in diabetes or by preventing amino acid uptake and maintaining normal kidney function in healthy conditions.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-29124-8 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29124-8

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-29124-8

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-29124-8